Celldex Research Corporation
Records under this name other than patents Celldex Research Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Celldex Research Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,169,325 | Antibodies that bind human CD27 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,180,566 | Antibodies that bind human CD27 and uses thereof Formerly held Lapsed on the fee record Ended Nov 23, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 23, 2025 | USPTO record |
| US 7,563,876 | Human monoclonal antibodies to dendritic cells Lapsed on the fee record Ended Jul 21, 2021 · USPTO record | Lapsed on the fee record | Ended Jul 21, 2021 | USPTO record |
| US 7,560,534 | Molecular conjugates comprising human monoclonal antibodies to dendritic cells Lapsed on the fee record Ended Jul 14, 2021 · USPTO record | Lapsed on the fee record | Ended Jul 14, 2021 | USPTO record |
| US 8,142,790 | Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells Lapsed on the fee record Ended Mar 27, 2020 · USPTO record | Lapsed on the fee record | Ended Mar 27, 2020 | USPTO record |
| US 9,259,459 | Antibody vaccine conjugates and uses therefor Formerly held Lapsed on the fee record Ended Feb 16, 2020 · USPTO record | Lapsed on the fee record | Ended Feb 16, 2020 | USPTO record |
| US 9,243,064 | Antibody vaccine conjugates and uses therefor Formerly held Lapsed on the fee record Ended Jan 26, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 26, 2020 | USPTO record |
| US 9,095,626 | Monoclonal antibodies to dendritic cells Formerly held Lapsed on the fee record Ended Aug 4, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 4, 2019 | USPTO record |
| US 6,258,358 | Targeted immunostimulation with bispecific reagents Lapsed on the fee record Ended Jul 10, 2013 · USPTO record | Lapsed on the fee record | Ended Jul 10, 2013 | USPTO record |
| US 6,682,928 | Cells expressing anti-Fc receptor binding components Lapsed on the fee record Ended Jan 27, 2012 · USPTO record | Lapsed on the fee record | Ended Jan 27, 2012 | USPTO record |